Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Spotlight on Proffered Papers Session 1

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2
Drugs in the curative RCHOP combination exhibit low cross-resistance but not pharmacologic synergy
Adam C Palmer
Harvard Medical School, Boston, MA, United States
from 2018 Advances in Malignant Lymphoma conference on June 23, 2018 11:00 AM-11:30 AM
MHC class II expression is associated with a distinct mutational profile and immune cell landscape of the microenvironment in GCB-DLBCL
Daisuke Ennishi
BC Cancer Agency, Vancouver, BC, Canada
from 2018 Advances in Malignant Lymphoma conference on June 23, 2018 11:00 AM-11:30 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2